Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.55M Sell
29,465
-80,973
-73% -$4.2M ﹤0.01% 1894
2026
Q1
$5.77M Buy
110,438
+99,142
+878% +$5.08M 0.01% 910
2025
Q4
$547K Sell
11,296
-152
-1% -$7.4K ﹤0.01% 2055
2025
Q3
$547K Buy
11,448
+7,339
+179% +$358K ﹤0.01% 1843
2025
Q2
$214K Buy
+4,109
New +$228K ﹤0.01% 2033
2025
Q1
Sell
-6,524
Closed -$353K 3443
2024
Q4
$353K Sell
6,524
-9,260
-59% -$537K ﹤0.01% 1625
2024
Q3
$956K Buy
+15,784
New +$921K ﹤0.01% 1259
2023
Q2
Sell
-10,246
Closed -$584K 3317
2023
Q1
$584K Buy
10,246
+4,314
+73% +$230K 0.01% 1253
2022
Q4
$304K Sell
5,932
-11,141
-65% -$567K ﹤0.01% 1717
2022
Q3
$793K Buy
+17,073
New +$924K 0.01% 1078
2022
Q2
Sell
-5,618
Closed -$280K 3774
2022
Q1
$280K Buy
+5,618
New +$275K ﹤0.01% 2283
2020
Q4
Sell
-7,604
Closed -$293K 2505
2020
Q3
$293K Buy
+7,604
New +$319K 0.01% 1156

Other funds holding UTL

HRT Financial's UTL Position: Q2 2026 in Review

HRT Financial reduced its Unitil (UTL) stake by 73% in Q2 2026, selling an estimated $4.2M and leaving 29,465 shares worth $1.55M. The position accounts for ﹤0.01% of the portfolio, ranked #1894.

HRT Financial first reported a position in UTL in Q3 2020 and has held it in 12 quarters since. The position peaked at $5.77M in Q1 2026. 243 funds tracked by Wall St. Rank hold UTL as of Q2 2026.

  • HRT Financial held 29,465 shares of Unitil worth $1.55M as of Q2 2026.
  • HRT Financial sold 80,973 Unitil shares in Q2 2026, an estimated $4.2M.
  • Unitil made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #1894 holding.
  • HRT Financial first reported a position in Unitil in Q3 2020 and has held it in 12 quarters since.
  • HRT Financial's Unitil position peaked at $5.77M in Q1 2026.
  • 243 funds tracked by Wall St. Rank held Unitil as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.